Pure Global
NCT03500718

Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation

Jawaharlal Institute of Postgraduate Medical Education & Research·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cochlear Hearing Loss
Drug/Device/Intervention
Cochlear implant
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Jawaharlal Institute of Postgraduate Medical Education & Research
Location
Puducherry, India
Timeline & enrollment
Phase
N/A
Start date
Feb 26, 2018
End date
Dec 31, 2019
Enrollment
44 participants
Primary outcome

Changes in threshold of ECAP after cochlear implantation.

Summary

After cochlear implantation, cochlear nerve is stimulated by giving a current over the
 electrodes placed in the cochlea and the current is measured by electrically evoked Compound
 Action Potential (ECAP).This ECAP is measured intra operatively, after 4 weeks( at switch
 on), after 3months and 6 months following cochlear implantation.

ICD-10 classifications
Other hearing lossOther specified hearing lossOtotoxic hearing lossHearing loss, unspecifiedSudden idiopathic hearing loss
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03500718
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT03500718 through Pure Global AI's free database. This phase not specified trial is sponsored by Jawaharlal Institute of Postgraduate Medical Education & Research and is currently Completed. The study focuses on Cochlear Hearing Loss. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.